Adial Pharmaceuticals Inc

Stock Chart, Company Information, and Scan Results

$0.39(as of Oct 15, 3:03 PM EST)

Stock Market Guides is not a financial advisor. Our content is strictly educational and should not be considered financial advice.

Adial Pharmaceuticals Inc Company Information, Fundamentals, and Technical Indicators

Stock Price$0.39
Ticker SymbolADIL
ExchangeNasdaq
SectorHealthcare
IndustryBiotechnology
Employees5
CountyUSA
Market Cap$8.1M

Adial Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the development of therapeutics for the treatment or prevention of addiction and related disorders. The company's lead product is AD04, a serotonin-3 antagonist, which is in Phase 3 clinical trials for the treatment of alcohol use disorder. It is also involved in the development of drug candidates for non-opioid pain reduction and other diseases and disorders. Adial Pharmaceuticals, Inc. was founded in 2010 and is based in Glen Allen, Virginia.

Adial Pharmaceuticals Inc In Our Stock Scanner

As of Oct 15, 2025
example chart graphic
Scan Name: Low PB RatioScan Type: Stock Fundamentals
As of ---
example chart graphic
Scan Name: Cash SurplusScan Type: Stock Fundamentals
As of ---
As of ---
As of ---
As of ---

Join Our Free Email List

Get emails from us about ways to potentially make money in the stock market.